William Blair & Company’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $47.4M | Sell |
340,345
-28,585
| -8% | -$4M | 0.14% | 146 |
|
|
2025
Q4 | $45.3M | Sell |
368,930
-8,434
| -2% | -$1.02M | 0.12% | 148 |
|
|
2025
Q3 | $41.9M | Sell |
377,364
-8,983
| -2% | -$1.02M | 0.11% | 157 |
|
|
2025
Q2 | $42.8M | Sell |
386,347
-11,908
| -3% | -$1.27M | 0.12% | 154 |
|
|
2025
Q1 | $44.6M | Sell |
398,255
-15,175
| -4% | -$1.57M | 0.13% | 147 |
|
|
2024
Q4 | $38.2M | Sell |
413,430
-8,040
| -2% | -$724K | 0.11% | 163 |
|
|
2024
Q3 | $35.3M | Sell |
421,470
-4,089
| -1% | -$312K | 0.1% | 160 |
|
|
2024
Q2 | $29.2M | Buy |
425,559
+7,082
| +2% | +$473K | 0.09% | 164 |
|
|
2024
Q1 | $30.7M | Sell |
418,477
-50,963
| -11% | -$3.92M | 0.1% | 163 |
|
|
2023
Q4 | $38M | Sell |
469,440
-2,160
| -0.5% | -$168K | 0.13% | 142 |
|
|
2023
Q3 | $35.3M | Sell |
471,600
-13,310
| -3% | -$1.02M | 0.14% | 141 |
|
|
2023
Q2 | $37.4M | Sell |
484,910
-2,871
| -0.6% | -$229K | 0.14% | 140 |
|
|
2023
Q1 | $40.5M | Sell |
487,781
-32,133
| -6% | -$2.66M | 0.16% | 129 |
|
|
2022
Q4 | $44.6M | Buy |
519,914
+34,625
| +7% | +$2.74M | 0.19% | 114 |
|
|
2022
Q3 | $29.9M | Sell |
485,289
-5,595
| -1% | -$353K | 0.14% | 146 |
|
|
2022
Q2 | $30.3M | Sell |
490,884
-26,806
| -5% | -$1.66M | 0.13% | 148 |
|
|
2022
Q1 | $30.8M | Sell |
517,690
-71,377
| -12% | -$4.56M | 0.11% | 177 |
|
|
2021
Q4 | $42.8M | Buy |
589,067
+12,984
| +2% | +$894K | 0.13% | 148 |
|
|
2021
Q3 | $40.2M | Sell |
576,083
-43,866
| -7% | -$3.08M | 0.14% | 148 |
|
|
2021
Q2 | $42.7M | Sell |
619,949
-110,273
| -15% | -$7.36M | 0.15% | 145 |
|
|
2021
Q1 | $47.2M | Buy |
730,222
+22,381
| +3% | +$1.44M | 0.18% | 131 |
|
|
2020
Q4 | $41.2M | Sell |
707,841
-112,322
| -14% | -$6.78M | 0.15% | 140 |
|
|
2020
Q3 | $51.8M | Sell |
820,163
-34,491
| -4% | -$2.39M | 0.22% | 98 |
|
|
2020
Q2 | $65.8M | Buy |
854,654
+50,397
| +6% | +$3.86M | 0.31% | 66 |
|
|
2020
Q1 | $60.1M | Sell |
804,257
-128,459
| -14% | -$8.88M | 0.38% | 59 |
|
|
2019
Q4 | $60.6M | Sell |
932,716
-91,413
| -9% | -$5.95M | 0.31% | 76 |
|
|
2019
Q3 | $64.9M | Sell |
1,024,129
-88,370
| -8% | -$5.78M | 0.37% | 63 |
|
|
2019
Q2 | $75.2M | Sell |
1,112,499
-248,567
| -18% | -$16.4M | 0.43% | 60 |
|
|
2019
Q1 | $88.5M | Buy |
1,361,066
+56,270
| +4% | +$3.74M | 0.54% | 45 |
|
|
2018
Q4 | $81.6M | Sell |
1,304,796
-18,876
| -1% | -$1.32M | 0.6% | 40 |
|
|
2018
Q3 | $102M | Sell |
1,323,672
-42,825
| -3% | -$3.23M | 0.63% | 38 |
|
|
2018
Q2 | $96.8M | Sell |
1,366,497
-139,679
| -9% | -$9.86M | 0.66% | 38 |
|
|
2018
Q1 | $114M | Sell |
1,506,176
-46,971
| -3% | -$3.73M | 0.8% | 27 |
|
|
2017
Q4 | $111M | Buy |
1,553,147
+5,011
| +0.3% | +$381K | 0.76% | 31 |
|
|
2017
Q3 | $125M | Buy |
1,548,136
+38,266
| +3% | +$2.93M | 0.94% | 18 |
|
|
2017
Q2 | $107M | Buy |
1,509,870
+2,768
| +0.2% | +$184K | 0.8% | 22 |
|
|
2017
Q1 | $103M | Sell |
1,507,102
-61,855
| -4% | -$4.35M | 0.83% | 22 |
|
|
2016
Q4 | $112M | Sell |
1,568,957
-243,236
| -13% | -$18.1M | 1.01% | 14 |
|
|
2016
Q3 | $143M | Sell |
1,812,193
-557,985
| -24% | -$45.3M | 1.27% | 7 |
|
|
2016
Q2 | $186M | Buy |
2,370,178
+66,039
| +3% | +$5.86M | 1.74% | 5 |
|
|
2016
Q1 | $212M | Sell |
2,304,139
-89,776
| -4% | -$8.1M | 1.99% | 4 |
|
|
2015
Q4 | $242M | Sell |
2,393,915
-406,216
| -15% | -$42.3M | 2.27% | 2 |
|
|
2015
Q3 | $275M | Sell |
2,800,131
-1,589,238
| -36% | -$177M | 2.38% | 2 |
|
|
2015
Q2 | $514M | Buy |
4,389,369
+126,132
| +3% | +$13.8M | 0.77% | 2 |
|
|
2015
Q1 | $418M | Sell |
4,263,237
-445,708
| -9% | -$45.3M | 0.64% | 6 |
|
|
2014
Q4 | $444M | Sell |
4,708,945
-148,459
| -3% | -$15.4M | 0.72% | 3 |
|
|
2014
Q3 | $517M | Sell |
4,857,404
-462,804
| -9% | -$45.3M | 0.88% | 1 |
|
|
2014
Q2 | $441M | Buy |
5,320,208
+32,165
| +0.6% | +$2.5M | 0.72% | 4 |
|
|
2014
Q1 | $375M | Buy |
5,288,043
+587,251
| +12% | +$46.1M | 0.62% | 11 |
|
|
2013
Q4 | $353M | Buy |
4,700,792
+233,360
| +5% | +$16.2M | 0.58% | 14 |
|
|
2013
Q3 | $281M | Sell |
4,467,432
-88,257
| -2% | -$5.27M | 0.5% | 26 |
|
|
2013
Q2 | $234M | Buy |
+4,555,689
| New | +$237M | 0.46% | 36 |
|
Other funds holding GILD
VCM
VPM
William Blair & Company's GILD Position: Q1 2026 in Review
William Blair & Company reduced its Gilead Sciences (GILD) stake by 7.7% in Q1 2026, selling an estimated $4M and leaving 340,345 shares worth $47.4M. The position accounts for 0.14% of the portfolio, ranked #146.
William Blair & Company first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $517M in Q3 2014. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- William Blair & Company held 340,345 shares of Gilead Sciences worth $47.4M as of Q1 2026.
- William Blair & Company sold 28,585 Gilead Sciences shares in Q1 2026, an estimated $4M.
- Gilead Sciences made up 0.14% of William Blair & Company's portfolio in Q1 2026, its #146 holding.
- William Blair & Company first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- William Blair & Company's Gilead Sciences position peaked at $517M in Q3 2014.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.